Latest Solutions
Can the intake technician explain the prescription intake process? ANS Teams should practice touring the
pharmacy, explain each work station, introduce team members and describe what their primary responsibility
is during prescription intake.
Can the pharmacist describe how they verify a prescription and when to conduct the Initial Assessment? ANS
The Pharmacist conducts a Prescription Data Review and DUR during prescription processing. In addition
they assess the appropriateness of the medication(s), gather a complete medication list (Medication
Reconciliation), check allergies, diagnosis and health conditions/comorbidities/medical history, therapeutic
goals based on possible outcomes of therapy, and patient's ability to self administer. The Pharmacist will
document the RPH Initial Assessment in Asembia before the medication is dispensed along with any
interventions taken.
Can the Pharmacist describe how to conduct a complete Medication Reconciliation? ANS The Pharmacist
completes a Medication Reconciliation during the Initial Assessment; when starting a new specialty drug, if at
the time of the 6-month Reassessment there were changes in the patients medications, and transition of care.
This involves reviewing the medication list to ensure it is accurate, and/or discussing with the patient, and/or
other providers to ensure it is accurate. The medication list must contain all prescription medications, OTC's,
herbals, and supplements the patient is taking. LocalSPRx > Community-Based Specialty > Quality &
Accreditation > Initial, Reassessment and Medication Reconciliation Guide - Asembia 1
Can the Pharmacist explain how the patient is educated on their medications, disease state, and patient care
management program? ANS Patients are verbally offered counseling at the start of therapy. During the
initial contact we explain our patient management process which includes refill reminder calls, clinician
monitoring, and the importance of the patient contacting us with any medication changes or issues. Written
medication leaflets are provided with the prescription and additional material is mailed (including links to
online resources) to the patients.
Can the Pharmacist explain how patients receive information on their medications and disease? ANS We
provide verbal education and written drug information leaflets. Other information is mailed to the patient in the
Welcome Booklet.
Can the Pharmacist explain how we facilitate transition of care for patients? ANS A medication profile is
made available to the patient or healthcare entitiy the patient is transferring to.
,Can the Pharmacist explain how drug adherence is promoted? ANS Initial counseling on the importance of
compliance, refill reminder calls, pill boxes, or recommendations to alleviate any side effects, and assistance
obtaining financial assistance as needed.
Can the Pharmacist explain how the individual needs of the patient are addressed? ANS If there are unique
needs or requests of the patient we will do our best to accommodate them. We will work with prescribers to
adjust their therapy if possible to meet their individual needs.
Can the Pharmacist explain how they collaborate with physicians or other healthcare providers involved in the
patients care? ANS We communicate with patients regularly in person and over the phone. If the patient
has any issues or if we have a recommendation/update we will call or fax their prescriber a note.
Can the Pharmacist explain how clinical Reassessments are conducted? ANS The patient's tolerance to the
medication and compliance is assessed by asking the patient questions while we are communicating with them
about refills and assessments. Any concerns gathered during the refill process are escalated to a pharmacist for
further evaluation/reassessment. In addition, at a minimum, a reassessment is conducted every 6 months and
documented in the RPH Reassessment. This includes a medication reconciliation to ensure we have a complete
and accurate medication list, check allergies and health conditions. (Hep-C patient assessments will NOT
trigger, they must be manually scheduled if needed)
Can the Pharmacist describe which type of patients we consider High Risk when taking specialty medications?
ANS Our high risk population consist of Pregnant, Pediatric (<18), and Elderly (≥60). These conditions
must be documented in IC+ and Asembia to ensure appropriateness of the medication and dose is prescribed.
Can the Pharmacist explain how patients At Risk of noncompliance are identified? ANS Through
discussion with the patient we may identify a patient that could benefit from additional medication, disease
state knowledge, or financial assistance if they have a lack of financial means to afford the medications. In
addition, we identify patients who have late or missed refills. We help the patient through these areas by
providing education and support to prevent or improve non-compliance.
Can the Pharmacist explain how we advocate for a patients access to drugs? ANS We have access to many
Limited Distribution Drugs (LDD) within the Walgreens chain. We also help with prior authorizations and get
patients signed up for financial assistance programs if needed.
Can team members explain how we help with prior authorizations and appeals to ensure access to
medications? ANS We help facilitate the process by working with the insurance company and coordinate
obtaining documents from the prescribers.
, Can team members explain how we refer patients to external support groups for help as needed? ANS We
refer patients to local or national disease support groups as well as other entities. The site should have a list of
support groups to refer to, the coordination of care job aid, as well as disease state resources on LocalSPRx >
Advocacy
Can team members explain how we refer patients to external pharmacies if the patients needs cannot be met?
ANS In situations where the patient's needs cannot be met by our pharmacy, (ie: Walgreens out of coverage
network) we inform the patient immediately and work to transfer care to the pharmacy the patient chooses.
Transfer logs/records are maintained in IC+
Can team members explain how we communicate rights and responsibilities to the patient? ANS Patient
rights and responsibilities are mailed along with the welcome booklet (excluding HIV patients) and is managed
through Asembia1. These materials are also posted on our website for patients who do not want to receive
mailing materials.
Is there a copy of the Expert Care for Complex Condition, Clients Bill of Rights, and other disease materials
for common disease services available in the pharmacy? ANS LocalSPRx > Community-Based Specialty >
Patient Education Materials > Patient Educational Materials and Client's Bill of Rights and Responsibilities.
Can team members explain how language barriers, cultural beliefs, and disabilities are addressed? ANS
Our team members speak to all patients in a culturally competent manner and review ingredients in
medications to accomodate cultural restrictions as requested. We have access to a translator tool via IC+,
Voyce Oral Services (855-296-8838) are available for languages not listed in IC+ and hearing impaired
customers. Written Language Translation Services are available via
Detailed information on Pharmacy Translation Services is available at StoreNet> RX > Patient Care> Patient
Services> Translation Services.
Can team members explain the process for communicating and collecting patient payments? ANS Since
majority of our billing is through on-line adjudication, we have this information and inform the patient upfront
of all charges as much as possible. We discuss and offer Express Pay where payment information can be safely
stored in the system and processed automatically upon their approval. In addtion the cash price is available
upon request (and on the patient's leaflet).If a patients insurance is out of network we will provide difference in
cost if available and requested.
Can the Pharmacist explain what the elements of a care plan are? ANS A Care Plan is comprised of a
Problem, Measurable goal with a target date, Intervention(s), Outcome(s) Patient motivation level assessment
and coordination of care documentation.